A detailed history of Nebula Research & Development LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 15,227 shares of NBIX stock, worth $1.93 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
15,227
Previous 13,649 11.56%
Holding current value
$1.93 Million
Previous $1.88 Billion 6.63%
% of portfolio
0.21%
Previous 0.3%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$114.58 - $153.15 $180,807 - $241,670
1,578 Added 11.56%
15,227 $1.75 Billion
Q2 2024

Aug 14, 2024

BUY
$130.86 - $143.19 $1.79 Million - $1.95 Million
13,649 New
13,649 $1.88 Billion

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.